iiinova — where your digital self keeps evolving

Reposted by Prostate Cancer UK Professionals

Royal Osteoporosis Society @royalosteosoc.bsky.social · 21/09/2026

Could we prevent more broken bones? Four APPGs are investigating whether people at risk of osteoporosis & fractures are being identified & supported early enough forms.cloud.microsoft/pages/respons…

001

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 21/08/2026

📢 Please share this opportunity The West Midlands Awareness and Empowerment Fund is now open for Expressions of Interest. Through a partnership with West Midlands Cancer Alliance, the fund will support community-led initiatives that raise awareness of prostate cancer among Black men.

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 04/08/2026

Working in prostate cancer care? Follow our new LinkedIn page for clinical updates, guidance, education & CPD, practical tools and patient info. Join a dedicated space for healthcare professionals to stay informed, connected and supported. buff.ly/GeYu30f #ProstateCancer #HealthProfessionals

Person with white beard resting chin on hand while looking at a laptop, wearing a black shirt with small crown and human-figure lapel pins and a wristband.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 27/07/2026

Sexual dysfunction is a common consequence of prostate cancer treatment, and many patients go unsupported due to a lack of discussion or delays in intervention. Watch Prof. Mike Kirby's video for an overview of the use of PDE5 inhibitors in patients treated for prostate cancer.

edu.prostatecanceruk.org

Top Tips for Primary Care: Optimising PDE5 inhibitor Use In Prostate Cancer Care – Prostate Cancer UK Education

An expert -led overview for primary care clinicians on the early, proactive use of PDE5 inhibitors in patients treated for prostate cancer.

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 22/07/2026

📣 Urologists needed to help reduce overtreatment of prostate cancer Help refine an e-learning resource to support discussions about active surveillance and treatments for localised prostate cancer. 90–120 min online focus group. Get involved ➡️ buff.ly/bhnFb7Z

A middle-aged black man receiving comforting support from a younger relative while they consult a nurse and a doctor in a clinic, holding a health leaflet and discussing his care.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/07/2026

Prostate Cancer UK grants of £500–£10,000 are available for projects raising awareness of prostate cancer among Black men. ➡️ Please share with eligible charities, CICs or CIOs 🕐️ Applications close on 31 July 2026 ✉️ Email bheinbox@prostatecanceruk.org to find out more

Call for organisations serving Black communities to apply for Prostate Cancer UK community grants to fund awareness, events, culturally tailored engagement and early-diagnosis outreach; grants £500–£5,000 (larger £5,000–£10,000); applications 1–31 Jul 2026; shows smiling Black men.

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 14/07/2026

Boost your clinical confidence in #prostatecancer care with free, bite-sized e-learning modules authored by radiotherapy and oncology expert Catherine Holborn. These interactive, evidence-based courses align with current guidelines and count towards your self-accredited #CPD. buff.ly/KaQlTRU

Man sitting on a couch in a living room reading an online course titled "Prostate Cancer Essentials: Part 2 – Diagnosing And Staging" on a laptop, suggesting he’s studying health information at home.

011

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 30/06/2026

📢 Prostate cancer specialists wanted Help refine an e-learning resource to support clinician–patient discussions and informed decision-making about active surveillance and treatment options for low/intermediate-risk prostate cancer. 90–120 min online focus group + £60. Register: buff.ly/qa3Cocf

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 24/06/2026

🩺 NHS England needs clinical & technical experts to join the evaluation panels for the PET-CT Phase 1 Procurement - shaping 50% of England's provision for the next 10 years. Looking for: - Radiologists / NM Physicians - Referring Consultants - Radiographers / Technologists - MPEs (1/2) 👇

100

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 22/06/2026

We're here to support anyone affected by prostate cancer - whether they need information about a diagnosis, someone who's had treatment to talk to, or help with side effects. We'll cover our support services in this webinar. 📅 24 June 🕕️ 6pm–7.30pm Signpost to patients: buff.ly/Cqxxr1W

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 22/06/2026

From the 29th June, The Patients Association will be hosting free webinars as part of Patient Partnership Week. This will bring together patients, professionals, policymakers, and researchers to explore what meaningful partnership looks like in practice. More information here ➡️ buff.ly/TLwgPdU

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 05/06/2026

What do the latest UK NSC recommendation on prostate cancer screening and TRANSFORM trial expansion mean for practice? Read our summary for health professionals, access FAQs and share your feedback: buff.ly/U2UnXx3

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 04/06/2026

Please share with patients our free webinar. Our upcoming webinar will help men feel less alone and more supported after a prostate cancer diagnosis, with information about our services available and insight from others with lived experience. 📅 24 June 🕕 6pm–7:30pm Details here: buff.ly/cX658LF

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 28/05/2026

Dr Alan McWilliam @manchester.ac.uk leads a #research team working to make #radiotherapy treatment more precise. Since 2021, we’ve supported his team to develop a way to more quickly identify men with #ProstateCancer who are not responding to treatment. 📙 Read more: buff.ly/fQjCGRM

Dr Alan McWilliam quote: This research could help make radiotherapy treatment more personalised by identifying those at risk of their cancer returning, while reducing side effects and improving quality of life.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 27/05/2026

NICE is recruiting a professional member for the Prostate Cancer: Diagnosis & Management committee. If you’re a health or social care professional with relevant expertise, this is a great chance to influence national guidance and improve patient outcomes. Read more & apply ➡️ buff.ly/qwyLij3

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 26/05/2026

Macmillan and @rc-pharm.bsky.social are seeking healthcare professionals’ views on managing medicines and polypharmacy during cancer care. Your insights will help improve medicines optimisation, patient support and care for people affected by cancer. Take the survey ➡️ buff.ly/yIrGMoV

Picture shows different colour pill/medicine packets

110

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 21/05/2026

Professor Val Macaulay @ndsurgicalsci.bsky.social led a research group investigating the role of IGF‑1 in #ProstateCancer. Since 2004, we’ve supported her team to explore whether drugs targeting IGF‑1 could help slow the growth of localised prostate cancer. 📙 Read more: buff.ly/GyaDLdr

Professor Val Macaulay quote: We hope our research will help uncover how IGF-1 drives prostate cancer growth and provide evidence that early cancers can be stopped from progressing.

111

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 19/05/2026

Could measuring ctDNA & serum PSA identify men with advanced #ProstateCancer who may benefit from treatment intensification? A team @ucl.ac.uk & the University of Trento, led by Profs Francesca Demichelis & Gert Attard, publish findings in @natcancer.nature.com. Grab a ☕ & read: lnkd.in/eeSkYZVX

Scientific Paper published in Nature Cancer, titled: Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study. Written by Jayaram et al.

100

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 14/05/2026

Dr Robert Kypta at @imperialcollegeldn.bsky.social leads a team exploring novel treatments for #ProstateCancer. Since 2022, we’ve supported his team to develop a new targeted drug delivery approach, helping protect healthy cells and reduce side effects. Read more 📙: bit.ly/4u2x383

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 08/05/2026

📢 Introducing Dr Shaun Scaramuzza, the first of our 2025 Career Acceleration Fellows! 🔬 Shaun’s research aims to improve early detection and treatment options for men at highest risk. Our 2026 round is still open for applications! You can apply here: buff.ly/3fXLLUz

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 07/05/2026

Dr Susan Heavey at @ucl.ac.uk leads a team focused on making drug development more effective. Since 2018, we’ve supported her team to use patient‑derived explants & spatial transcriptomics to identify the most promising #ProstateCancer treatments. 📙 Read more: bit.ly/2ADGYs9

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 05/05/2026

Could PSA levels measured during & after treatment, together with radiological features, help guide personalised treatment decisions for men with #ProstateCancer? A team led by Prof Gert Attard @ucl.ac.uk share new findings in @thelancetoncol.bsky.social. Grab a ☕️ & read: doi.org/10.1016/S147...

Scientific Paper published in The Lancet Oncology, titled: On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials. Written by Kayani et al.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 29/04/2026

Strengthening the UK #prostatecancer clinical research pipeline.🔬 Our April in person CRSG meeting sparked rich discussion on major research proposals & UK wide collaboration. Huge thanks to our proposal presenters, CRSG and Early Career members. 👏 📙https://bit.ly/4mGKnfK

110

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 28/04/2026

How have the PACE trials influenced radiotherapy treatment for #ProstateCancer? Profs Nicholas van As & @profemmahall.bsky.social @icr.ac.uk share learnings from a decade of trials, including Prostate Cancer UK-funded PACE-NODES, in @ijrobp.bsky.social. Grab a ☕ & read: doi.org/10.1016/j.ij...

Scientific Paper titled: The PACE Trials: A Decade of Progress and the Lessons Learned. Written by van As et al.

120

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 27/04/2026

The April edition of Research News is here! Read about: 💙 The TRANFORM screening trial. 📢 Our new LinkedIn channel for prostate cancer researchers. 🔬 Research stories with impact. 🏆 Researcher achievements. 💰 Funding opportunities. Read it here 📰 : buff.ly/k09eMvo

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 24/04/2026

Prostate Cancer UK funded a team led by Prof Noel Clarke at the Movember FASTMAN Centre of Excellence to analyse bone scans from the STAMPEDE trial. They explored whether adding radiotherapy to the prostate could help men whose cancer had spread. 📙 prostatecanceruk.org/research/res...

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 23/04/2026

🥼 Professor Simon Mackay @unistrathclyde.bsky.social leads a team developing new treatments for men with advanced #ProstateCancer. 💊 In 2019, we funded Simon to further develop his first-in-class IKKα inhibitor. 📙 Read more about Simon's innovative #research: prostatecanceruk.org/research/res...

Graphic with a man icon holding a sign reading 'Research We Fund' on the left hand side, a portrait photo of Professor Simon Mackay in the top right corner, and a quote from Simon reading 'Thanks to the funding from Prostate Cancer UK, we have brought this treatment one step closer to clinical trials. After all this time, I'd be over the moon if I could make that difference to men affected by prostate cancer'.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 22/04/2026

📣 Job Opportunity: Biobank Manager for TRANSFORM Discovery. Play a central role in developing a world-leading high-quality data & tissue resource and help TRANSFORM outcomes for men affected by #ProstateCancer. Full details ⤵️ www.imperial.ac.uk/jobs/search-...

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 21/04/2026

Could hypoxia and angiogenesis gene expression help personalise #ProstateCancer radiotherapy? Funded by our Movember FASTMAN Centre of Excellence, Prof Hoskin and Prof Choudhury @christieinstitute.bsky.social share new findings in Clinical Oncology. Grab a ☕ and read: bit.ly/4sHE25b

Graphic of a recently published research article, titled 'Predicting high-dose-rate brachytherapy boost benefit using hypoxia and angiogenesis gene expression in localised prostate cancer' by Lodhi et al.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

Our final Patient Research Partner speech comes from Patrick. Diagnosed with Stage 4 #ProstateCancer in 2020, Patrick is dedicated to raising awareness, visiting many organisations and businesses. A huge thank you to all of our inspirational Patient Research Partners 👏

020

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

It’s time for the final session of From Ideas to Innovation 2026 🗣️ The focus is on advanced #ProstateCancer, and we’re delighted to be joined by speakers Professor Gerhardt Attard, Dr Ashwin Sachdeva and Dr Emily Grist.

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

Kicking off the first session of the afternoon 🎤 Simon and Hayley from our research team are sharing how @prostatecanceruk.bsky.social can support researchers - from making key introductions, to our open access reimbursement scheme, to helping their work reach the audiences that matter.

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

Derek’s father died from oligometastatic #ProstateCancer, before Derek was diagnosed with the disease himself some years later. After his surgery, Derek began volunteering for @prostatecanceruk.bsky.social and served as a patient representative on our research committees for over 10 years.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

Next up is a session on primary and metastatic cancer. Great to welcome Professor Charlotte Bevan and PhD student Nuria Fortuno from Imperial College London (@IP-London.bsky.social). ➡️ Find out more about their work: bit.ly/46Bqsal

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

Our first Patient Research Partner today is Vincent. Shortly after retiring, he was diagnosed with #ProstateCancer, with no symptoms beforehand. After a radical robotic prostatectomy and excellent care, he achieved a curative outcome with minimal side effects.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 16/04/2026

We’re now in the auditorium for the first session of Day 2 🎤 Our Director of Research, Dr Matthew Hobbs, opens the day with an update on work to develop the @prostatecanceruk.bsky.social 10-year research strategy.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

A great first day at From Ideas to Innovation! 👏 Following a day of talks exploring the latest research in risk, treatment resistance, screening, and imaging, the first poster session is now underway—showcasing a wide range of high quality prostate cancer research.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Our final Patient Research Partner talk of the day comes from Robert. Successfully treated for #ProstateCancer in 2003, he served on Prostate Cancer UK’s Research Advisory Group, PPI and Research Strategy groups until 2025, and has supported fundraising events including #MarchforMen.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

We close the day with a session on imaging and staging in #ProstateCancer. Professor Hashim Ahmed (@londonprostate1.bsky.social) and Dr Martin Connor from @ip-london.bsky.social are joining us to share more about their work in this area. ➡️ Find out more: bit.ly/4moUAwq

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Our next session explores barriers to thriving in the #ProstateCancer research community, with opening reflections from Black researchers. We’ll also explore practical ways the community can drive positive change and ensure everyone can thrive and make an impact for men.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Sue’s husband was diagnosed with #ProstateCancer at 52. After running out of licensed treatment options, he joined a Phase 3 abiraterone trial that extended his life and improved his quality of life. It inspired Sue’s passion for research, early diagnosis and better treatment.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Our next session is all about TRANSFORM - the biggest #ProstateCancer screening trial in 20 years. Thanks to Professor Rakesh Heer, Professor Rhian Gabe, and Dr Nikhil Mayor (@nikhilmayor.bsky.social) for speaking. ➡️ Learn more: bit.ly/3xSHfYS @ip-london.bsky.social

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Robin is our next Patient Research Partner on stage at the @royalcollegeofgps.bsky.social. Diagnosed with low-risk, localised #ProstateCancer in 2006, he has been a volunteer with Prostate Cancer UK since 2008 and has served on national research and funding committees as a patient representative.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

After a short break, we're back underway with our next session on #ProstateCancer risk. Speakers Professor Colin Cooper and Mr Harveer Dev are part of a team using genetic data to predict progression and reduce recurrence. ➡️Find out more: bit.ly/4ecqVoZ

011

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Each of our sessions features a Patient Research Partner - men affected by #ProstateCancer or their families. First up is Simon, diagnosed in 2011 aged 49. He’s taken on many fundraising challenges, raising thousands for charity - including £45,000 for Prostate Cancer UK in 2018.

010

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Our first session explores treatment resistance in #ProstateCancer. Two of today’s speakers: Professor Johann de Bono and Dr Alec Paschalis, work in this area alongside @asharpmedonc.bsky.social ➡️ Find out more: bit.ly/4c9IzHm

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 15/04/2026

Our From Ideas to Innovation meeting is officially underway! 🎉 Thrilled to see researchers arriving this morning at @royalcollegeofgps.bsky.social for a full programme of research presentations, networking and insightful discussions.

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 14/04/2026

Could RNA-targeting identify drivers of AR-V7 linked #ProstateCancer? A team including Prof de Bono @icr.ac.uk, supported by our Movember London Centre of Excellence, share new findings as part of a @jci.org double-header. Grab a ☕ and read: bit.ly/4cjfadS

Graphic of a newly published research article published in The Journal of Clinical Investigation titled 'Splicing factor TRA2B enhances synthesis of androgen receptor variant AR-V7 in prostate cancer cells' by Brittain et al.

021

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 14/04/2026

📣 Announcing the Trailblazers in Cancer Research Meeting Bringing together the British Association for Cancer Research early career community to share research, network, and hear from renowned cancer researchers. 📍 Manchester 🗓️ 26–27 November 2026 Read more 👉 bacr.org.uk/event/save-t...

000

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 14/04/2026

📢 Upcoming European Prostate Cancer Alliance webinar! This webinar will focus on epigenetics in #ProstateCancer, with confirmed speakers including Prof Wilbert Zwart @zwartlab.bsky.social, Prof Leigh Ellis, and Filipa Moreira Silva. 📆 Monday 22 June 2026, 15:00-17:15

022